TM6SF2 and hepatocellular carcinoma: A NASH genetic risk score (GRS), combining the variants in the PNPLA3, TM6SF2 and HSD17B13 genes, predicted a 12-fold increased risk for cirrhosis and a ~29-fold increased risk for HCC [47].